Pfizer, Valneva overcome CRO issues to finish phase 3 recruitment for Lyme disease vaccine
Pfizer, Valneva overcome CRO issues to finish phase 3 recruitment for Lyme disease vaccine
jkeenan
Tue, 12/05/2023 - 10:19
СМИ24.net — правдивые новости, непрерывно 24/7 на русском языке с ежеминутным обновлением *
